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Introduction
5-aminolaevulinic acid (5-ALA) is a natural precursor of
haemoglobin. Exogenously administered 5-ALA can lead
to intracellular accumulation of fluorescent porphyrins
in malignant tissues, such as glioblastoma. 5-ALA is
increasingly used to improve tumour visualisation and
enable more optimal resection of malignant gliomas. In
vitro, 5-ALA can cause oxidative damage to rat liver
mitochondria. In vivo, rats exposed to 5-ALA developed
increased lactate levels; possibly because inhibition of
oxidative metabolism [1]. Univariate data also suggested
an effect of 5-ALA in neurosurgical patients [2]. Since
lactate levels are widely used to monitor patients, we
performed multivariate analysis on the impact of 5-ALA
on lactate levels.
Objectives
Asses the relation of preoperative 5-ALA on postoperative
systemic lactate levels in patients undergoing surgery for
malignant brain tumours.
Methods
In an observational study in a cohort of neurosurgical
patients who underwent resection of a suspected malig-
nant glioma and were postoperatively admitted to our
ICU, we compared lactate levels between patients who
received 5-ALA preoperatively (5-ALA group) and those
who did not (control group). The decision to use 5-ALA
was at the discretion of the neurosurgeon and was based
on the specific tumour characteristics on preoperative
imaging. If fluorescent-guided resection was scheduled,
the patient received 20 mg/kg of 5-ALA (Gliolan, Medac,
Germany) orally 2 hours before the induction of anaesthe-
sia. All patients received high-dose dexamethasone. Peri-
and postoperative lactate and glucose levels were routinely
obtained during the ICU stay in all included patients in
this study using a point-of-care analyzer blood gas
analyser.
Results
From 2007 to 2014 we included 350 patients aged 56 ± 14,
60% males. 89 patiens (25%) received 5-ALA. These
patients were older than controls (62 ± 8 vs. 53 ± 15;p <
0.001); duration of operation did not differ between the
control and 5-ALA groups (NS). On day 0 the mean maxi-
mum lactate in the 5-ALA vs control groups was 2.83 ±
1.34 vs 2.47 ± 1.24 mmol/L (p = 0.02). On the first post-
operative day the lactate levels were similar. Multivariate
analysis showed that age (p = 0.02), duration of operation
(p = 0.04) and glucose (p < 0.001), but not 5-ALA (p =
0.43) were related with lactate.
Conclusions
5-ALA use was only univariately associated with increased
postoperative lactate levels. MV-analysis, strongly points
to a central role of hyperglycemia, as was recently also
observed after cardiac surgery [3].
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